Alivus Life Sciences Ltd. - ALIVUS, 543322 corporate action history

Alivus Life Sciences Ltd. NSE: ALIVUS | BSE: 543322

Slowing Down Stock

Download real time

912.80 -16.35 (-1.76%)

27.03% Fall from 52W High

1,620

NSE+BSE Volume

NSE 01 Oct, 2025 9:07 AM (IST)

Alivus Life Sciences Ltd. Bonus history

Alivus Life Sciences Ltd. has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Alivus Life Sciences Ltd. Split history

Alivus Life Sciences Ltd. has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Alivus Life Sciences Ltd.

Alivus Life Sciences Ltd. has declared 5 dividends since Nov. 22, 2021.

In the past 12 months, Alivus Life Sciences Ltd. has declared an equity dividend amounting to ₹5.00 per share.

At the current share price of ₹912.8000, Alivus Life Sciences Ltd.'s dividend yield is 0.55%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
01 Sep 2025	5.00	FINAL	01 Sep 2025	Equity Share
17 Oct 2023	22.50	INTERIM	17 Oct 2023	Equity Share
24 Mar 2023	21.00	INTERIM	24 Mar 2023	Equity Share
15 Sep 2022	10.50	FINAL	-	Equity Share
22 Nov 2021	10.50	INTERIM	23 Nov 2021	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Alivus Life Sciences Ltd.

The latest board meeting for Alivus Life Sciences Ltd. took place on 01 Aug 2025, for the purpose of Quarterly Results

Ex-Date	Purpose	Notes
01 Aug 2025	Quarterly Results	-
15 May 2025	Audited Results & Final Dividend	-
23 Jan 2025	Quarterly Results	-
24 Oct 2024	Quarterly Results	-
25 Jul 2024	Quarterly Results	-
25 Apr 2024	Audited Results	-
23 Jan 2024	Quarterly Results	-
20 Oct 2023	Quarterly Results	-
09 Oct 2023	Interim Dividend	-
21 Jul 2023	Quarterly Results	-

See all Board Meetings for Alivus Life Sciences Ltd.

Alivus Life Sciences Ltd. Rights history

Alivus Life Sciences Ltd. has not issued any rights since Jan 1, 2000.

See all Rights History for Alivus Life Sciences Ltd.

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

132 Votes:

Buy 75.0%

Sell 12.12%

Hold 12.88%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >